Clinical Trial Update: Sarcoma Study of MORAb-004 Utilization: Research and Clinical Evaluation [Phase 2]

View source ↗

Summary

Phase 2 trial update for MORAb-004 in metastatic soft tissue sarcoma with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft-tissue Sarcoma

Drugs mentioned

• MORAb-004

Snippet

Sponsor: Morphotek | Conditions: Metastatic Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2019-08-21